Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK

AIMS: Familial hypercholesterolaemia (FH) is a vastly under-diagnosed genetic disorder, associated with early development of coronary heart disease and premature mortality which can be substantially reduced by effective treatment. Patents have recently expired on high-intensity statins, reducing FH...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Marion, Pears, Robert, Miedzybrodzka, Zofia, Haralambos, Kate, Cather, Moyra, Watson, Melanie, Humphries, Steve E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837803/
https://www.ncbi.nlm.nih.gov/pubmed/28387827
http://dx.doi.org/10.1093/eurheartj/ehx111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837803/
https://www.ncbi.nlm.nih.gov/pubmed/28387827
http://dx.doi.org/10.1093/eurheartj/ehx111

Ejemplares similares